Mapping chronic pain with brain blueprints
For decades, doctors attempting to treat chronic pain with brain stimulation faced a fundamental problem: they knew electricity could help, but they could not see exactly where to send it. A small but revealing study now suggests a new approach: first draw a detailed map of the pain itself, then send precisely targeted signals to disrupt it. This is the difference between guessing which switch controls which circuit and reading the blueprints before touching a single breaker.
The old method, deep brain stimulation, or DBS, relies on thin wires implanted deep in the brain, connected to a battery pack placed in the chest. The technique has become a standard treatment for Parkinson’s disease, helping to calm the tremors that define that condition. Researchers have also tried it for depression and other psychiatric disorders, with varying degrees of success. But when applied to chronic pain, the results have been frustratingly inconsistent, working for some patients while doing nothing for others. That spottiness, scientists now suspect, comes from the nature of pain itself, which is not a single signal but a complex combination of sensory input, chemical messages, and emotional responses.
The new case studies, published in a recent issue of the journal Brain Stimulation, turned the old approach on its head. Instead of placing electrodes in a standard location and hoping for the best, the research team began by mapping each patient’s unique pain signature. Over three days, they systematically sent tiny pulses of electricity through temporary electrodes to different spots in the brains of three volunteers, all of whom suffered from severe and chronic face pain. This process revealed the specific regions where stimulation could interrupt the pain signals for each individual.
From Blind Guessing to Precision Targeting
The shift in thinking here echoes a transformation that has already happened in other fields. Consider how heart attacks are treated today compared to fifty years ago. Previously, doctors could only administer drugs and hope the body would heal itself. Now, they perform angiograms, dye studies that reveal the exact location of a blocked artery, before placing a stent precisely where it is needed. The new brain-mapping approach follows the same logic: a complex system cannot be effectively treated until its internal state is visible. Chronic pain, like a blocked artery, is not a general condition but a specific, localized problem that demands a specific, localized solution.
The complexity of pain has long been the barrier to effective treatment. Unlike the acute agony of a broken arm, which fades as the bone heals, chronic pain is generated by changes in the brain and spinal cord themselves. It persists long after the original injury has resolved, becoming a disease in its own right. Neurosurgeon Michael Lim of Stanford University School of Medicine, who was not involved in the study, points out how limited the options have been for these patients, who carry a great deal of suffering. [1] The results of this new research, he says, open up a fresh avenue for treating this sort of pernicious pain, one that has been closed for far too long.
This personalized approach acknowledges something that older, one-size-fits-all treatments ignored: every brain is different. Vivek Buch, a neurosurgeon and neuroscientist at Stanford University, explains that the experience of pain is built by collections of brain networks, including those that handle sensory input, chemical signals, and even emotional components. [2] Somehow these distinct streams come together to create an integrated signal that gives a person the perception of pain. Chronic pain, as well as psychiatric disorders such as depression and obsessive-compulsive disorder, are just not one-size-fits-all, Buch says, and the inconsistent results of past DBS trials now make perfect sense in that light.
The Three-Day Blueprint That Changed Everything
The study’s premise was deceptively simple, yet it required a level of patience and precision that previous efforts had lacked. Buch and his colleagues recruited three people suffering from severe, chronic face pain, a condition notoriously resistant to treatment. These volunteers underwent surgery to have temporary electrodes inserted through small holes in the skull into key brain regions. Then, over the next three days, the researchers systematically sent small blips of electricity through these wires to different spots in the volunteers’ brains, essentially asking each brain where its pain switch was located. This mapping yielded specific information about each person’s pain, according to Karl Deisseroth, a neuroscientist, psychiatrist, and Howard Hughes Medical Institute investigator at Stanford. [2]
The results were as varied as the individuals themselves, which is precisely the point. One of the volunteers did not get much relief from any of the combinations of stimulation, a disappointing outcome that nonetheless provided valuable data. Two of the three people experienced significant improvement in their pain. For one participant, a woman in her forties, the positive response during testing was so clear that she went on to have four permanent electrode wires implanted in the regions that had responded well. Six and twelve months later, she is still feeling better, sending the research team routine text messages to report her progress. The second woman who found relief during testing is planning to receive a permanent implant soon, Buch says.
The person who did not experience much relief from the electrical stimulation still taught the researchers a great deal. Successful outcomes are important, Deisseroth notes, but it is just as important to identify if the definitive treatment is not going to work. This is a form of negative knowledge that the field desperately needs. To have an objective measure guiding whether or not a patient is taken through a particular course of treatment, Deisseroth says, is a dream in psychiatry and psychiatry-adjacent fields. The ability to test a treatment quickly and see if it works, before committing a patient to permanent surgery, is a fundamental advance over the old trial-and-error approach.
A Confirming Echo Across the Field
The potential of this brain-mapping approach extends far beyond the three patients in this small case series. The researchers themselves are explicit about their ambitions, hoping to explore more conditions with this technique, both as a therapeutic effort and as a way to learn more about how the brain works. Deisseroth, speaking from his perspective in psychiatry, captures the sense of possibility that this work has unleashed. He says he does not know that there is a ceiling on where we can go, a statement that reflects the profound shift from treating symptoms blindly to understanding the underlying neural architecture of suffering.
This line of research finds a confirming echo in the broader scientific community, where the idea of personalized brain stimulation is gaining traction. The fundamental insight, that a week-long mapping session can lead to lasting relief, is being explored by other groups working on similar questions. They are not just using the same tools, but asking the same fundamental question: can we find the individual signature of a brain disorder and target it with precision? The parallel work in depression and obsessive-compulsive disorder, where DBS has also shown inconsistent results, is now being re-examined through this new lens of personalized mapping.